BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/13/2014 7:02:00 PM | Browse: 966 | Download: 1161
 |
Received |
|
2013-11-28 14:36 |
 |
Peer-Review Started |
|
2013-11-29 13:23 |
 |
To Make the First Decision |
|
2014-03-12 16:57 |
 |
Return for Revision |
|
2014-03-20 20:10 |
 |
Revised |
|
2014-04-10 19:59 |
 |
Second Decision |
|
2014-07-29 08:35 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2014-07-29 09:03 |
 |
Articles in Press |
|
2014-07-29 09:03 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
2014-08-06 23:22 |
 |
Typeset the Manuscript |
|
2014-10-14 16:28 |
 |
Publish the Manuscript Online |
|
2014-12-13 19:01 |
Category |
Endocrinology & Metabolism |
Manuscript Type |
Review |
Article Title |
Transdifferentiation of pancreatic α-cells into insulin-secreting cells: From experimental models to underlying mechanisms
|
Manuscript Source |
Invited Manuscript |
All Author List |
Jieli Lu, Rami Jaafer, Rémy Bonnavion, Philippe Bertolino and Chang-Xian Zhang |
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
Agence National de Recherche |
ANR 2010 BLAN 1240 01 |
Ligue contre le Cancer du Rhône and de la Loire |
|
CMIRA program of Region Rhône-Alpes |
12004959-01 |
Fondation ARC pour la Recherche sur le Cancer, France |
SFI20101201530 |
National Nature Science Foundation of China |
NSFC81170719 |
National Nature Science Foundation of China |
81370960 |
Shanghai New Excellent Youth Program |
XYQ2011009 |
|
Corresponding Author |
Jieli Lu, MD, PhD, Sino-French Life Science and Genomic Center, the E-Institute of Shanghai, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University, Xuhui District, Shanghai 200025, China. jielilu@hotmail.com
|
Key Words |
α-cell; β-cell; Transdifferentiation; Diabetes mellitus; Cell-replacement therapy |
Core Tip |
Recent works highlighted the phenomenon of transdifferentiation of pancreatic α cells into β cells, which has drawn much attention in the field. Considering that α-cell transdifferentiation could be used as a new strategy of cell replacement therapy for the treatment of diabetes, because of the presence of α cells in the pancreas of both type 1 and 2 diabetics, we believe that it is relevant to elucidate the cellular and molecular events in α- to β-cell conversion. Our review focuses on the recent experimental α-cell transdifferentiation models, highlighting the insight provided by these works into the candidates and contexts revealed to be involved in this process.
|
Publish Date |
2014-12-13 19:01 |
Citation |
Lu J, Jaafer R, Bonnavion R, Bertolino P, Zhang CX. Transdifferentiation of pancreatic α-cells into insulin-secreting cells: From experimental models to underlying mechanisms. World J Diabetes 2014; 5(6): 847-853 |
URL |
http://www.wjgnet.com/1948-9358/full/v5/i6/847.htm |
DOI |
http://dx.doi.org/10.4239/wjd.v5.i6.847 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345